Considering coexpression of CyPA and CD147 axis and the limitation of single-biomarker prediction in cancer prognosis, we expected CyPA/CD147 axis could be not only promising potential biomarkers in glioma prognosis and liquid biopsy but also a potential therapeutic target. The gene discussed is PPIA; the disease is cancer.